Celldex Therapeutics, Inc. Repayments of Convertible Debt
Celldex Therapeutics, Inc. (CLDX) reported Repayments of Convertible Debt of $12.50 million for the 12-month period ending 2011-12-31, per its 10-K filed 2014-03-03.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfConvertibleDebt · last filed 2014-03-03
- Celldex Therapeutics, Inc. repayments of convertible debt for the quarter ending 2011-12-31 was $0.00.
- Celldex Therapeutics, Inc. repayments of convertible debt for the quarter ending 2011-09-30 was $0.00.
- Celldex Therapeutics, Inc. repayments of convertible debt for the quarter ending 2011-06-30 was $0.00.
- Celldex Therapeutics, Inc. repayments of convertible debt for the quarter ending 2011-03-31 was $12.50M.
- Celldex Therapeutics, Inc. repayments of convertible debt for fiscal 2011 was $12.50M.
| Period end | Repayments of Convertible Debt 3 month | Repayments of Convertible Debt 6 month | Repayments of Convertible Debt 9 month | Repayments of Convertible Debt 12 month |
|---|---|---|---|---|
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | $0.00 derived: sum of 2 quarters · filed 2014-03-03 | $0.00 derived: sum of 3 quarters · filed 2014-03-03 | $12.50M 10-K · filed 2014-03-03 |
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-02 | $0.00 derived: sum of 2 quarters · filed 2012-11-02 | $12.50M 10-Q · filed 2012-11-02 | |
| 2011-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | $12.50M 10-Q · filed 2012-08-09 | ||
| 2011-03-31 | $12.50M 10-Q · filed 2012-05-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |